Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1976 3
1977 1
1978 1
1979 1
1981 1
1982 2
1983 2
1984 1
1985 1
1986 2
1987 4
1988 2
1989 2
1990 3
1991 3
1992 6
1993 8
1994 5
1995 12
1996 9
1997 10
1998 11
1999 15
2000 10
2001 14
2002 16
2003 11
2004 11
2005 21
2006 21
2007 16
2008 14
2009 13
2010 16
2011 15
2012 19
2013 18
2014 25
2015 41
2016 35
2017 33
2018 37
2019 44
2020 57
2021 48
2022 43
2023 49
2024 55
2025 46

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

744 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for dose wg
Search for Dotse WG instead (1 results)
Evinacumab for Homozygous Familial Hypercholesterolemia.
Raal FJ, Rosenson RS, Reeskamp LF, Hovingh GK, Kastelein JJP, Rubba P, Ali S, Banerjee P, Chan KC, Gipe DA, Khilla N, Pordy R, Weinreich DM, Yancopoulos GD, Zhang Y, Gaudet D; ELIPSE HoFH Investigators. Raal FJ, et al. N Engl J Med. 2020 Aug 20;383(8):711-720. doi: 10.1056/NEJMoa2004215. N Engl J Med. 2020. PMID: 32813947 Clinical Trial.
METHODS: In this double-blind, placebo-controlled, phase 3 trial, we randomly assigned in a 2:1 ratio 65 patients with homozygous familial hypercholesterolemia who were receiving stable lipid-lowering therapy to receive an intravenous infusion of evinacumab (at a dose of 1 …
METHODS: In this double-blind, placebo-controlled, phase 3 trial, we randomly assigned in a 2:1 ratio 65 patients with homozygous familial h …
PK/PD and Bioanalytical Considerations of AAV-Based Gene Therapies: an IQ Consortium Industry Position Paper.
Kavita U, Sun K, Braun M, Lembke W, Mody H, Kamerud J, Yang TY, Braun IV, Fang X, Gao W, Gupta S, Hofer M, Liao MZ, Loo L, McBlane F, Menochet K, Stubenrauch KG, Upreti VV, Vigil A, Wiethoff CM, Xia CQ, Zhu X, Jawa V, Chemuturi N. Kavita U, et al. AAPS J. 2023 Jul 31;25(5):78. doi: 10.1208/s12248-023-00842-1. AAPS J. 2023. PMID: 37523051 Review.
This position paper comes from the Novel Modalities Working Group (WG), part of the International Consortium for Innovation and Quality in Pharmaceutical Development (IQ). ...Last, best practices and recommendations for use of clinical and nonclinical data to project human …
This position paper comes from the Novel Modalities Working Group (WG), part of the International Consortium for Innovation and Quali …
How to manage poor mobilisers.
Worel N. Worel N. Transfus Apher Sci. 2024 Jun;63(3):103934. doi: 10.1016/j.transci.2024.103934. Epub 2024 Apr 18. Transfus Apher Sci. 2024. PMID: 38678982 Review.
Autologous hematopoietic progenitor cell transplantation (ASCT) has been used for more than five decades to treat malignant and non-malignant diseases. Successful engraftment after high-dose chemotherapy relies on the ability to collect sufficient CD34 + hematopoietic prog …
Autologous hematopoietic progenitor cell transplantation (ASCT) has been used for more than five decades to treat malignant and non-malignan …
Radiation dose management systems-requirements and recommendations for users from the ESR EuroSafe Imaging initiative.
Loose RW, Vano E, Mildenberger P, Tsapaki V, Caramella D, Sjöberg J, Paulo G, Torresin A, Schindera S, Frija G, Damilakis J; European Society of Radiology (ESR). Loose RW, et al. Eur Radiol. 2021 Apr;31(4):2106-2114. doi: 10.1007/s00330-020-07290-x. Epub 2020 Sep 21. Eur Radiol. 2021. PMID: 32959080 Free PMC article.
The EuroSafe Imaging campaign of the European Society of Radiology created a working group (WG) on "Dose Management" with the aim to provide European recommendations on the implementation of dose management systems (DMS) in clinical practice. The WG fo …
The EuroSafe Imaging campaign of the European Society of Radiology created a working group (WG) on "Dose Management" with the …
Hemi-ablative low-dose-rate prostate brachytherapy for unilateral localised prostate cancer.
Langley S, Uribe J, Uribe-Lewis S, Franklin A, Perna C, Horton A, Cunningham M, Higgins D, Deering C, Khaksar S, Laing R. Langley S, et al. BJU Int. 2020 Mar;125(3):383-390. doi: 10.1111/bju.14948. Epub 2019 Dec 23. BJU Int. 2020. PMID: 31705700 Clinical Trial.

Sexual potency was conserved in 73% and 67% of HG and WG patients, respectively (P = 0.84). Post-implant prostate-specific antigen (PSA) kinetics revealed that baseline PSA was reduced at 24 months by 78% and 88% in HG and WG patients, respectively (P < 0.05). Tr

…
Sexual potency was conserved in 73% and 67% of HG and WG patients, respectively (P = 0.84). Post-implant prostate-specific antigen (P …
Hydroxychloroquine in recurrent pregnancy loss: data from a French prospective multicenter registry.
Dernoncourt A, Hedhli K, Abisror N, Cheloufi M, Cohen J, Kolanska K, McAvoy C, Selleret L, Ballot E, Mathieu d'Argent E, Chabbert Buffet N, Fain O, Kayem G, Mekinian A. Dernoncourt A, et al. Hum Reprod. 2024 Sep 1;39(9):1934-1941. doi: 10.1093/humrep/deae146. Hum Reprod. 2024. PMID: 38942601 Free PMC article.
The main endpoint was the occurrence of a pregnancy continuing beyond 12 WG, and the secondary endpoint was the occurrence of a live birth. MAIN RESULTS AND THE ROLE OF CHANCE: One hundred pregnancies with HCQ exposure in 74 women were assessed. ...Sixty-two (62%) pregnanc …
The main endpoint was the occurrence of a pregnancy continuing beyond 12 WG, and the secondary endpoint was the occurrence of a live …
CADORmed: a tool for internal dose assessment.
Landry B, Breustedt B, Castellani CM, Lopez MA, Sierra I, Navarro JF, Roberts G. Landry B, et al. Radiat Prot Dosimetry. 2023 May 24;199(8-9):922-929. doi: 10.1093/rpd/ncad093. Radiat Prot Dosimetry. 2023. PMID: 37225218
CADORmed is a free bespoke Excel tool for committed effective dose assessment using latest dose coefficients from ICRP OIR publications. The field of application of CADORmed is special monitoring, and it is not available for the dose assessment of chronic exp …
CADORmed is a free bespoke Excel tool for committed effective dose assessment using latest dose coefficients from ICRP OIR pub …
Dosimetry modeling for focal high-dose-rate prostate brachytherapy.
Mason J, Al-Qaisieh B, Bownes P, Thwaites D, Henry A. Mason J, et al. Brachytherapy. 2014 Nov-Dec;13(6):611-7. doi: 10.1016/j.brachy.2014.06.007. Epub 2014 Jul 29. Brachytherapy. 2014. PMID: 25085456
PURPOSE: The dosimetry of focal high-dose-rate prostate brachytherapy was assessed. Dose volume histogram parameters, robustness to source position errors, and Monte Carlo (MC) simulations were compared for whole-gland (WG), hemi-gland (HEMI), and ultra-focal …
PURPOSE: The dosimetry of focal high-dose-rate prostate brachytherapy was assessed. Dose volume histogram parameters, robustne …
Consumption of whole grains and risk of type 2 diabetes: A comprehensive systematic review and dose-response meta-analysis of prospective cohort studies.
Ghanbari-Gohari F, Mousavi SM, Esmaillzadeh A. Ghanbari-Gohari F, et al. Food Sci Nutr. 2022 Mar 10;10(6):1950-1960. doi: 10.1002/fsn3.2811. eCollection 2022 Jun. Food Sci Nutr. 2022. PMID: 35702290 Free PMC article. Review.
Prospective observational studies investigating the association between WG intake and risk of T2D were included. The random-effects model calculates the summary relative risks by contrasting categories and linear and nonlinear dose-response associations. ...Each add …
Prospective observational studies investigating the association between WG intake and risk of T2D were included. The random-effects m …
A Step towards Concrete with Partial Substitution of Waste Glass (WG) in Concrete: A Review.
Ahmad J, Zhou Z, Usanova KI, Vatin NI, El-Shorbagy MA. Ahmad J, et al. Materials (Basel). 2022 Mar 30;15(7):2525. doi: 10.3390/ma15072525. Materials (Basel). 2022. PMID: 35407857 Free PMC article. Review.
However, the chemical composition of waste glass (WG) is promoted to be used as a partial substitution of binding or filler (aggregate) material in concrete production. ...Moreover, this study reveals that the optimum dose of waste glass is important to minimize the …
However, the chemical composition of waste glass (WG) is promoted to be used as a partial substitution of binding or filler (aggregat …
744 results